全文获取类型
收费全文 | 1744篇 |
免费 | 157篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 94篇 |
妇产科学 | 16篇 |
基础医学 | 208篇 |
口腔科学 | 32篇 |
临床医学 | 147篇 |
内科学 | 350篇 |
皮肤病学 | 43篇 |
神经病学 | 48篇 |
特种医学 | 159篇 |
外科学 | 228篇 |
综合类 | 149篇 |
预防医学 | 128篇 |
眼科学 | 14篇 |
药学 | 160篇 |
中国医学 | 39篇 |
肿瘤学 | 100篇 |
出版年
2023年 | 9篇 |
2022年 | 17篇 |
2021年 | 27篇 |
2020年 | 24篇 |
2019年 | 22篇 |
2018年 | 28篇 |
2017年 | 19篇 |
2016年 | 25篇 |
2015年 | 36篇 |
2014年 | 53篇 |
2013年 | 52篇 |
2012年 | 64篇 |
2011年 | 78篇 |
2010年 | 94篇 |
2009年 | 72篇 |
2008年 | 54篇 |
2007年 | 55篇 |
2006年 | 73篇 |
2005年 | 58篇 |
2004年 | 47篇 |
2003年 | 54篇 |
2002年 | 45篇 |
2001年 | 55篇 |
2000年 | 54篇 |
1999年 | 53篇 |
1998年 | 59篇 |
1997年 | 67篇 |
1996年 | 58篇 |
1995年 | 49篇 |
1994年 | 39篇 |
1993年 | 37篇 |
1992年 | 25篇 |
1991年 | 25篇 |
1990年 | 26篇 |
1989年 | 40篇 |
1988年 | 32篇 |
1987年 | 38篇 |
1986年 | 31篇 |
1985年 | 30篇 |
1984年 | 24篇 |
1983年 | 13篇 |
1982年 | 19篇 |
1981年 | 13篇 |
1980年 | 22篇 |
1979年 | 11篇 |
1977年 | 12篇 |
1976年 | 9篇 |
1975年 | 11篇 |
1972年 | 10篇 |
1971年 | 8篇 |
排序方式: 共有1918条查询结果,搜索用时 15 毫秒
91.
Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study 总被引:15,自引:0,他引:15
Kips JC O'Connor BJ Langley SJ Woodcock A Kerstjens HA Postma DS Danzig M Cuss F Pauwels RA 《American journal of respiratory and critical care medicine》2003,167(12):1655-1659
Antagonizing the effect of interleukin (IL)-5 is a potential new treatment strategy in allergic disorders. We evaluated the safety, biological activity, and pharmacokinetics of SCH55700, a humanized anti-human IL-5 antibody, in subjects with severe persistent asthma treated with oral or high doses of inhaled steroids. In a double-blind, randomized, multicenter trial, a rising single dose of SCH55700 (0.03 mg/kg [n = 2], 0.1 mg/kg [n = 4], 0.3 mg/kg [n = 6], or 1.0 mg/kg [n = 12]) or placebo (n = 8) was administered intravenously. SCH55700 dose dependently reduced circulating eosinophil counts. At a dose of 1.0 mg/kg, the decrease remained significant up to Day 30 [(0.07 +/- 0.01) x 10(9)/L versus (0.23 +/- 0.04) x 10(9)/L at baseline] (mean +/- SEM) (p = 0.05). After administration of SCH55700 at 0.3 and 1.0 mg/kg, a trend toward improvement in baseline FEV1 was observed, which reached significance 24 hours after the 0.3-mg/kg dose (p = 0.019 versus placebo). No significant changes occurred in other clinical indices of disease activity. Adverse events were not different between active treatment and placebo. We conclude that SCH55700 is a biologically active anti-human IL-5 antibody that can be safely used in severe steroid-treated asthma. Its therapeutic potential needs to be addressed in specifically designed efficacy trials. 相似文献
92.
Lung function at one month of age as a risk factor for infant respiratory symptoms in a high risk population 下载免费PDF全文
Murray CS Pipis SD McArdle EC Lowe LA Custovic A Woodcock A;National Asthma Campaign-Manchester Asthma Allergy Study Group 《Thorax》2002,57(5):388-392
BACKGROUND: Abnormal premorbid lung function is a risk factor for subsequent wheezing in children with one or no atopic parent. This study was undertaken to establish whether early lung function in high risk infants (both parents atopic) was a risk factor for respiratory symptoms in infancy and to examine the influence of maternal asthma, smoking, and allergen exposure during pregnancy on any association. METHODS: Infants were recruited from the NAC Manchester Asthma and Allergy Study cohort at birth. Partial forced expiratory flow volume technique under sedation was carried out to determine maximal flow at FRC (V'maxFRC). Children were followed prospectively and parents completed a standard respiratory questionnaire at one year of age. RESULTS: Sixty nine term infants (34 boys; 88% mothers non-smokers; no household pets) underwent respiratory function testing. Size adjusted V'maxFRC was significantly lower in infants who had recurrent wheeze during the first year of life (mean 1.3 ml/s/cm, 95% CI 0.99 to 1.60) than in those who did not (mean 2.03 ml/s/cm, 95% CI 1.71 to 2.36; p=0.01). V'maxFRC was also significantly lower in infants who had recurrent cough symptoms. In multivariate regression analysis, when adjusted for age at test, sex, maternal asthma, smoking and maternal mattress Der 1 levels, a lower size adjusted V'maxFRC score remained strongly associated with wheezing (OR 0.37, 95% CI 0.18 to 0.77, p=0.007). Maternal smoking also remained an independent risk factor (OR 29.85, 95% CI 2.46 to 362.5, p=0.008). CONCLUSION: Significantly diminished lung function was present in high risk infants who subsequently wheezed and coughed. This was independent of maternal exposure to mite allergen, asthma, and smoking during pregnancy. 相似文献
93.
94.
95.
目的:通过对突发性聋病人血中一氧化氮(NO)、丙二醛(MDA)、超氧化物歧化酶(SOD)含量的检洲,探讨突聋与血氧自由基和自由基的清除剂SOD之间的关系。方法:采用硝酸还原酶法测定了30例突聋病人血中NO含量,并以25例同期体检正常的健康人为对照组;同时还用硫代巴比妥酸比色法测定MDA含量,用黄嘌呤氧化酶法测定SOD含量。砖呆;应用金纳多、能量合剂、克林臭(即马来酸桂哌齐特,钙通道阻滞药)联合静脉输入,突聋各组的听力均有不同程度提高,有效率在78.57%以上。治疗后同对照组相比,血清NO、MDA水平明显低于患病之初,而SOD活性明显高于治疗之前,P〈0.01。结论;检测突聋病人血中N0、MDA、SOD的含量,能帮助我们探讨突聋的发病机理,估计预后。血氧自由基的升高可能是突聋发病因素之一,而SOD的含量可以帮助我们估计预后。 相似文献
96.
F Haque ST Fazal SA Ahmad SZ Abbas S Naseem 《Journal of Medical Imaging and Radiation Oncology》2006,50(1):63-65
Primary osteogenic sarcoma of the skull is an exceedingly rare condition. An adult male patient is described, who had a painless swelling in the right forehead that had rapidly enlarged in the previous 6 months. Radiological investigations showed a large destructive mass lesion involving the right side of the frontal bone with extension into the frontal sinus, causing marked extradural compression of brain parenchyma. Histopathological examination confirmed the lesion to be primary osteogenic sarcoma. 相似文献
97.
98.
维甲酸和联合应用神经营养因子对新生大鼠神经干细胞分化的影响 总被引:1,自引:0,他引:1
目的研究全反式维甲酸(ATRA)及联合应用神经营养因子(BDNF,GDNF)对体外培养的神经干细胞(NSCs)分化的影响。方法取新生SD大鼠的前脑室下带(SVZ)区,按NSCs的常规培养方法分离、培养。用免疫细胞化学法鉴定巢蛋白(nestin)、微管相关蛋白-2(MAP-2)、胶质原纤维酸性蛋白(GFAP)的表达,以此来观察ATRA、BDNF、GDNF单独或联合应用对次代神经球细胞分化的作用。结果原代及次代神经球均显示nestin阳性,并可分化为MAP-2阳性神经元样细胞及GFAP阳性胶质细胞样细胞。1μmol/LATRA可促进NSCs分化为MAP-2阳性细胞的比例达(29.14±5.00)%,显著高于对照组的(7.19±1.21)%,差异有高度统计学意义(P〈0.001)。ATRA联合应用10ng/ml的BDNF或GDNF,与单独使用ATRA比较,并不显著提高NSCs分化为MAP-2阳性细胞的比例。结论ATRA可促进神经干细胞向神经元方向分化,ATRA联合应用BDNF或GDNF无明显的协同作用。 相似文献
99.
Relations between age, metabolic control, disease adjustment and psychological aspects in insulin-dependent diabetes mellitus 总被引:1,自引:0,他引:1
B Lernmark G Dahlqvist P Fransson B Hägglöf SA Ivarsson J Ludvigsson S Sjöblad G Thernlund 《Acta paediatrica (Oslo, Norway : 1992)》1996,85(7):818-824
The relations between age, metabolic control, disease adjustment, and psychological factors in boys and girls with recently diagnosed insulin-dependent diabetes mellitus (IDDM) were studied. Older girls had significant higher postremission glycosylated haemoglobin A (Hb Alc ) levels ( p = 0.008). Girls with more hospitalizations had a lower developmental level ( p = 0.05), and had significantly more problems in the behavioural rating ( p = 0.05). Boys with more hospitalizations had a more external locus of control ( p = 0.01), more difficulties with disease adjustment, more emotional problems, and were also clinically assessed as having more behavioural problems. Boys showing more difficulties in psychological adjustment to the disease also had higher postremission Hb A1c levels ( p = 0.02). Although Swedish children with IDDM of short disease duration do not differ from healthy children in important psychological aspects, older girls and a small group of problematic younger boys are at risk of developing metabolic imbalance after a short disease duration. 相似文献
100.
JW Gregory SA Greene RT Jung CM Scrimgeour MJ Rennie 《Archives of disease in childhood》1993,68(2):205-209
Fourteen children receiving one year of recombinant human growth hormone (rhGH) treatment underwent measurement of serial changes in body composition (measured by skinfold thickness, bioelectrical impedance, and H2(18)O dilution), resting energy expenditure (REE, estimated by ventilated hood indirect calorimetry), and total free living daily energy expenditure (TEE, measured by the doubly labelled water technique). Mean height velocity increased from 4.9 to 8.6 cm/year after six months of treatment. Fat free mass (FFM) increased more during the first six weeks (24.4 g/day) than from six to 26 weeks of treatment (6.8 g/day); fat mass decreased by 7.2 g/day and 1.1 g/day respectively. The six week increase in REE (kJ/day) was maintained after six months of treatment, though expressed per kilogram FFM (kJ/kgFFM/day), returned to pretreatment values by three months. Height velocity increases at six months correlated with six week changes in fat mass measured by skinfold thickness and REE, though use of this relationship to predict growth response in individuals is limited by the wide 95% prediction intervals. No significant changes in growth, body composition, or energy expenditure were observed between six and 12 months of treatment, in either patients who had initially responded well to treatment or those who were poor initial responders to treatment and who had their dose of rhGH doubled after six months. 相似文献